Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-336-SE23 | 29-12-2023 | Compania de Asistencia al Viajero de Chile Limitada | Aceptada | $734.400 |
| 2980-334-SE23 | 27-12-2023 | Identicard SpA | Recepcion Conforme | $799.751 |
| 2980-335-SE23 | 27-12-2023 | Identicard SpA | Recepcion Conforme | $2.670.717 |
| 2980-332-AG23 | 26-12-2023 | Accion Grafica Publicitaria SpA | Recepcion Conforme | $916.300 |
| 2980-327-SE23 | 22-12-2023 | Novartis Chile S.A. | Aceptada | $728.855 |
| 2980-328-SE23 | 22-12-2023 | Novofarma Service S.A. | Aceptada | $3.340.449 |
| 2980-329-SE23 | 22-12-2023 | Novartis Chile S.A. | Aceptada | $5.619.542 |
| 2980-330-SE23 | 22-12-2023 | Novartis Chile S.A. | Recepcion Conforme | $3.512.214 |
| 2980-331-AG23 | 22-12-2023 | Synthon Chile Limitada | Recepcion Conforme | $1.649.340 |
| 2980-321-AG23 | 20-12-2023 | Impresiones Sercat Limitada | Recepcion Conforme | $499.800 |
| 2980-326-SE23 | 20-12-2023 | Laboratorio Lkm Chile SpA | Aceptada | $8.353.800 |
| 2980-314-AG23 | 14-12-2023 | Laboratorios Recalcine S.A. | Recepcion Conforme | $659.736 |
| 2980-315-AG23 | 14-12-2023 | Laboratorios Richmond Chile Limitada | Recepcion Conforme | $899.640 |
| 2980-316-AG23 | 14-12-2023 | Inversiones Sb S.A. | Recepcion Conforme | $963.900 |
| 2980-317-SE23 | 14-12-2023 | Novartis Chile S.A. | Recepcion Conforme | $1.390.743 |
| 2980-318-AG23 | 14-12-2023 | Comercial Red Office Limitada | Aceptada | $1.427.674 |
| 2980-319-AG23 | 14-12-2023 | Proveedores Integrales Prisa S.A. | Recepcion Conforme | $679.871 |
| 2980-320-AG23 | 14-12-2023 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Recepcion Conforme | $928.200 |
| 2980-322-AG23 | 14-12-2023 | Alembic Pharmaceuticals SpA | Recepcion Conforme | $779.688 |
| 2980-324-AG23 | 14-12-2023 | Siron Pharma SpA | Recepcion Conforme | $631.890 |
| 2980-325-SE23 | 14-12-2023 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $3.873.914 |
| 2980-306-SE23 | 06-12-2023 | Novartis Chile S.A. | Recepcion Conforme | $8.189.808 |
| 2980-303-AG23 | 01-12-2023 | Clara Andrea Molina Santibanez | Recepcion Conforme | $463.992 |
| 2980-309-AG23 | 01-12-2023 | Varifarma Chile SpA | Recepcion Conforme | $642.600 |
| 2980-307-SE23 | 01-12-2023 | Novartis Chile S.A. | Recepcion Conforme | $4.214.656 |
| 2980-308-SE23 | 01-12-2023 | Novartis Chile S.A. | Recepcion Conforme | $5.619.542 |
| 2980-310-AG23 | 01-12-2023 | Synthon Chile Limitada | Recepcion Conforme | $1.649.340 |
| 2980-311-SE23 | 01-12-2023 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $2.342.277 |
| 2980-312-AG23 | 01-12-2023 | Siron Pharma SpA | Recepcion Conforme | $1.332.800 |
| 2980-313-SE23 | 01-12-2023 | Comercializadora de Alimentos Especializados, Medicamentos y Dispositivos Medico | Aceptada | $3.063.060 |
